+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Nausea and vomiting in the patient with advanced cancer: an overview of prevalence, causes and assessment



Nausea and vomiting in the patient with advanced cancer: an overview of prevalence, causes and assessment



Collegian 8(1): 40-42




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 049661196

Download citation: RISBibTeXText

PMID: 15484632


Related references

Nausea and vomiting in the patient with advanced cancer: an overview of pharmacological and non-pharmacological management. Collegian 8(2): 41-42, 2001

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Annals of Oncology 27(Suppl 5): V119-V133, 2016

Nausea and vomiting in the patient with advanced cancer. Journal of Pain and Symptom Management 3(2): 81-85, 1988

An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Supportive Care in Cancer 14(4): 348-353, 2006

Danish national special interest group in nausea and vomiting has developed national guidelines to improve the nursing care of the cancer patient with nausea and vomiting. European Journal of Cancer 37(Suppl. 6): S405, 2001

Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer. Journal of Pain and Symptom Management 9(1): 48-50, 1994

Translation and psychometric assessment of the Persian version of the Rhodes Index of Nausea, Vomiting and Retching (INVR) scale for the assessment of chemotherapy-induced nausea and vomiting. European Journal of Cancer Care 23(6): 811-818, 2015

Test retest reliability and concurrent validity of the morrow assessment of nausea and emesis mane for the assessment of cancer chemotherapy related nausea and vomiting. Journal of Psychopathology & Behavioral Assessment 10(2): 107-116, 1988

Chemotherapy. An overview of nausea and vomiting in the cancer patient: etiology and management of serious complications of chemotherapy. Aaohn Journal 35(4): 179-182, 1987

Dexamethasone enhances the effect of tropisetron and ondansetron against nausea and vomiting against nausea and vomiting after patient-controlled analgesia. Di 1 Jun Yi Da Xue Xue Bao 22(2): 159-161, 2002

Danish national special interest group in nausea and vomiting has made an audit on nausea and vomiting with cancer patients receiving chemotherapy. EJC Suppl.s 1(5): S369-S370, 2003

Nausea and vomiting in advanced cancer. British Medical Bulletin 96: 175-185, 2010

Nausea and vomiting in advanced cancer. European Journal of Pharmacology 722: 187-191, 2014

Predictive factors for nausea or vomiting in patients with cancer who receive oral oxycodone for the first time: is prophylactic medication for prevention of opioid-induced nausea or vomiting necessary?. Journal of Palliative Medicine 17(6): 683-687, 2014

Metaanalyses of acustimulation effects on nausea and vomiting across different patient populations: a brief overview of existing evidence. Explore 2(3): 200-201, 2006